Full Press Release Details
PellePharm To Present Topical Patidegib And Skin Cancer Epidemiological Data At The 7th International Investigative Dermatology Meeting.
BBIO
PellePharm To Present Topical Patidegib And Skin Cancer Epidemiological Data At The 7th International Investigative Dermatology Meeting
Key Takeaway: PellePharm To Present Topical Patidegib And Skin Cancer Epidemiological Data At The 7th International Investigative Dermatology Meeting
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+41%
120-day peak, hindsight
Typical move
3.6%
average across 13 past catalysts
Cash runway
~30 mo
Minimal dilution risk
Lead asset
acoramidis
Phase 3 · Amyloidosis